KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update
Company provides nearly 80% statewide comprehensive insurance coverage in Utah under contract with providers such as Medicare, Select Health, Medicaid,...
Year: 2024
Full Alliance Group, Inc. (OTC: FAGI) Wholly Owned Subsidiary Dynamaxx Health Inc. Secures Its Own Manufacturing Contract for Medical Devices for MAXX Health Clinics
TAMPA, FL / ACCESSWIRE / August 14, 2024 / Full Alliance Group, Inc. (OTC PINK:FAGI) is pleased to announce that...
Vienna Vikings Football Team Signs Partnership Agreement With the CBD Vault
SCOTTSDALE, AZ / ACCESSWIRE / August 14, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly-owned subsidiary, The...
Moderna and Coursera Launch Free Course on mRNA Technology
Companies share joint commitment to leveraging technology for STEM educationAccessible education on cutting-edge science and technology represents critical step toward...
Kalm Therapeutics Emerges From Stealth With an Oversubscribed Seed Round
HUNTSVILLE, AL / ACCESSWIRE / August 14, 2024 / Kalm Therapeutics is pleased to announce the $700,000 oversubscribed closing of...
Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central America
SIRE Veterinario, SA Selected as Distribution Partner to Launch Zomedica® Products into Costa Rica ANN ARBOR, MI / ACCESSWIRE /...
ADMA Biologics Announces Partial Paydown of Revolving Credit Facility
Cash on Hand Utilized to Repay $30 Million of Revolving Credit Facility to Ares Capital with No Prepayment Penalties Lowers...
American Shared Hospital Services Announces Second Quarter 2024 Earnings Conference Call
Call Scheduled for Today at 6:30 PM ETSAN FRANCISCO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE...
Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
GLEN ALLEN, Va., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage...
RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
Phase III clinical trial is evaluating RenovoGem™ for the treatment of Locally Advanced Pancreatic Cancer UNMC opened enrollment of TIGeR-PaC...
Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range
• ONP-002 stability eliminates need for cumbersome cold storage• No FDA-approved pharmaceutical treatment available for concussion SARASOTA, Fla., Aug. 14,...
Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s Disease and Plans to Pursue a Development Partnership
Company reviews goals and significance of the study and outlines development strategy in Mild Cognitive Impairment due to Alzheimer’s diseaseROCHESTER,...
Precision Optics Announces Pricing of $1.4 Million Registered Direct Offering of Common Stock
GARDNER, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI) (the “Company”), a leading designer and...
Aclarion Announces First Commercial Agreement in Michigan
Sheridan Community Hospital is the First Healthcare Institution in Michigan With Nociscan Agreement Expands Nociscan Access to John Keller, MD,...
GRI Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Company focused on execution of lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) GRI-0621 interim data readout...
Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
Declared development candidate MGX-001 for the treatment of hemophilia A; plans to present 12-month NHP durability study data in September...
Invivyd Reports Second Quarter 2024 Financial Results and Recent Business Highlights
PEMGARDA™ launched commercially in Q2 2024 with $2.3 million of net product revenueNotable acceleration of commercial results in early Q3...
Kent Kresa to Retire from MannKind’s Board of Directors; Steven B. Binder to be Appointed to the Board
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on...
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr
WILMETTE, Ill., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing...
IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update
Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:...